Evidence map›Paper›PMID 40191199›Full record

ArticleFrontiers in immunology2025

Inflammatory markers activation associated with vapor or smoke exposure in Wistar rats.

Ewelina Wawryk-Gawda, Michał K Zarobkiewicz, Marta Wolanin-Stachyra, Violetta Opoka-Winiarska

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ewelina Wawryk-GawdaDepartment of Paediatric Pulmonology and Rheumatology, Medical University of Lublin, Lublin, Poland.
Michał K ZarobkiewiczDepartment of Clinical Immunology, Medical University of Lublin, Lublin, Poland.
Marta Wolanin-StachyraDepartment of Paediatrics, Pulmonology and Rheumatology, University Children's Hospital of Lublin, Lublin, Poland.
Violetta Opoka-WiniarskaDepartment of Paediatric Pulmonology and Rheumatology, Medical University of Lublin, Lublin, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Electronic cigarettes (e-cigarettes) were introduced two decades ago as a safer alternative to traditional cigarettes, aiming to assist in smoking cessation. However, the global use of e-cigarettes has surged, with the highest prevalence among adolescents and young adults. Despite their popularity, the safety of e-cigarettes remains controversial, with emerging evidence linking their use to various health risks, including cardiovascular issues, respiratory diseases, and a condition known as e-cigarette or vaping use-associated lung injury (EVALI). In this study, we investigated the inflammatory response in rats exposed to e-cigarette vapor compared to traditional cigarette smoke. We measured the serum concentrations of inflammatory markers such as IL-10, IFN-γ, IL-5, IL-2, TNF-α, GM-CS, IL-4, IL-9, IL-17F, IL-17A, IL-13, and IL-22 in the serum of rats subjected to 6 weeks of exposure. We assessed the activation of

Indexed as

E-Cigarette VaporInflammationInflammation MediatorsSmokeVapingAnimalsBiomarkersCytokinesElectronic Nicotine Delivery SystemsLungMaleRatsRats, WistarBiomarkersCytokinesE-Cigarette VaporInflammation MediatorsSmokeelectronic cigarettesimmuneinterleukinssmokevapor

Identifiers

PMID40191199
PMCPMC11968385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.